Journal of Applied Physiology, Vol 72, Issue 5 1868-1886, Copyright © 1992 by American Physiological Society

ARTICLES

Pulmonary angiotensin-converting enzyme substrate hydrolysis during exercise

J. Dupuis, C. A. Goresky, J. W. Ryan, J. L. Rouleau and G. G. Bach
McGill University Medical Clinic, Montreal General Hospital, Quebec, Canada.

We examined exercise-induced changes in indicator-dilution estimates of the angiotensin-converting enzyme first-order kinetic parameter, the ratio of a normalized maximal enzymatic conversion rate to the Michaelis constant (Amax/Km), which, under stable enzymatic conditions, will vary with the pulmonary vascular surface area accessible to vascular substrate, the extravascular lung water (an index of the proportion of lung tissue perfused), and the central blood volume (from pulmonary trunk to aorta). Experiments were performed in 10 mongrel dogs at rest and through two increasing levels of treadmill exercise, with the use of two vascular space tracers (labeled erythrocytes and albumin), a water space tracer ([1,8-14C]-octanediol), and a vascular endothelium surface area marker, benzoyl-Phe-Gly-Pro ([3H]BPGP), which is a pharmacologically inactive angiotensin-converting enzyme substrate. The exercise-induced increase in cardiac output was accompanied by a linear increase in central blood volume, and dilutional extravascular lung water rapidly increased to an asymptotic proportion close to 100% of postmortem vascular lung water. There was an average 55% [3H]BPGP hydrolysis, which did not vary with flow, and the computed Amax/Km increased linearly with exercise. We conclude that exercise results in complete lung tissue recruitment and increases the pulmonary vascular surface area available for BPGP hydrolysis linearly with flow, so that pulmonary vascular recruitment continues after full tissue recruitment.

This article has been cited by other articles:

				S. E. Orfanos, A. Armaganidis, C. Glynos, E. Psevdi, P. Kaltsas, P. Sarafidou, J. D. Catravas, U. G. Dafni, D. Langleben, and C. Roussos Pulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Acute Lung Injury Circulation, October 17, 2000; 102(16): 2011 - 2018. [Abstract] [Full Text] [PDF]

				S. E. Orfanos, D. Langleben, J. Khoury, R. D. Schlesinger, L. Dragatakis, C. Roussos, J. W. Ryan, and J. D. Catravas Pulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Humans Circulation, March 30, 1999; 99(12): 1593 - 1599. [Abstract] [Full Text] [PDF]

				M. P. Merker, S. H. Audi, B. M. Brantmeier, K. Nithipatikom, R. S. Goldman, D. L. Roerig, and C. A. Dawson Proline in vasoactive peptides: consequences for peptide hydrolysis in the lung Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L341 - L350. [Abstract] [Full Text] [PDF]

				S. Prié, T. K. Leung, P. Cernacek, J. W. Ryan, and J. Dupuis The Orally Active ETA Receptor Antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid (LU 135252) Prevents the Development of Pulmonary Hypertension and Endothelial Metabolic Dysfunction in Monocrotaline-Treated Rats J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1312 - 1318. [Abstract] [Full Text]

				P. Mathieu, M. Carrier, J. Dupuis, J. Ryan, and L. C. Pelletier L-Arginine Prevents Cyclosporin A-Induced Pulmonary Vascular Dysfunction Ann. Thorac. Surg., August 1, 1997; 64(2): 414 - 420. [Abstract] [Full Text]

				C. A. Goresky, A. Simard, and A. J. Schwab Increased Hepatocyte Permeability Surface Area Product for 86Rb With Increase in Blood Flow Circ. Res., May 19, 1997; 80(5): 645 - 654. [Abstract] [Full Text]

				J. Dupuis, D. J. Stewart, P. Cernacek, and G. Gosselin Human Pulmonary Circulation Is an Important Site for Both Clearance and Production of Endothelin-1 Circulation, October 1, 1996; 94(7): 1578 - 1584. [Abstract] [Full Text]